Elevance reports Q3 results and raises guidance
The company reported $50.4 billion in operating revenue and increased its full-year earnings outlook based on strong segment performance.
See the latest news and media coverage for Elevance. We track all announcements, press releases, and industry mentions in real time, all in one place.
Health insurer and whole-health services provider
elevancehealth.comLast updated
In short: Elevance reported Q3 earnings beat and raised guidance while navigating Medicaid and Medicare pressures in 2026.
The company reported $50.4 billion in operating revenue and increased its full-year earnings outlook based on strong segment performance.
Operating revenue was $49.8 billion, up 0.8% year-over-year, with adjusted diluted EPS of $7.45.
Operating revenue reaches $49.5 billion, up 1.5%. Adjusted diluted EPS hits $12.58. FY 2026 adjusted EPS guidance raised to at least $26.75.
Operating revenue reached $49.3B in Q4 and $197.6B for the year. Adjusted EPS was $3.33 in Q4 and $30.29 annually. FY 2026 outlook projects at least $25.50 adjusted EPS.
Elevance Health raises its 2026 outlook. Elevance Health stock costs EUR 385.35 on October 22, 2026; revenue rose 0.7 percent ...
Investors are continuing to watch how the insurer navigates costs in its Medicare Advantage and Medicaid portfolios.
The healthcare giant boosted its 2026 earnings outlook by $2 a share and signaled next year's adjusted earnings will top Wall Street estimates.
States jacked up their Medicaid rates in July, a positive development for the insurer. Elevance now thinks its Medicaid margin will be better than its...
Track Elevance and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Elevance and other trending companies.